Search research articles
Contact Us
Filters
Showing results (261-270 of 294) with videos related to
Page
of 30
Sort By:
Nature Communications
|
July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Urologic Oncology
|
September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
Noah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Nature Communications
|
February 14, 2024
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2019
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer
Venkatrao Vantaku, Jianrong Dong, Chandrashekar R Ambati, et al.
Cell Reports. Medicine
|
August 1, 2025
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer
Matthew V Holt, Yongchao Dou, Meggie N Young, et al.
Trials
|
October 4, 2023
Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses
Andrew R DiNardo, Moshe Arditi, Ashish M Kamat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2017
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study
Neal D Shore, Stephen A Boorjian, Daniel J Canter, et al.
Open Forum Infectious Diseases
|
January 28, 2025
BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Santiago Carrero Longlax, Kent J Koster, Ashish M Kamat, et al.
European Urology
|
September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 294) with videos related to
Sort By:
Page
of 30
Nature Communications
|
July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.
JAMA Oncology
|
November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer
Andrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Urologic Oncology
|
September 13, 2015
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
Noah M Hahn, Beatrice S Knudsen, Siamak Daneshmand, et al.
Nature Communications
|
February 14, 2024
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2019
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer
Venkatrao Vantaku, Jianrong Dong, Chandrashekar R Ambati, et al.
Cell Reports. Medicine
|
August 1, 2025
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer
Matthew V Holt, Yongchao Dou, Meggie N Young, et al.
Trials
|
October 4, 2023
Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses
Andrew R DiNardo, Moshe Arditi, Ashish M Kamat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2017
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study
Neal D Shore, Stephen A Boorjian, Daniel J Canter, et al.
Open Forum Infectious Diseases
|
January 28, 2025
BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Santiago Carrero Longlax, Kent J Koster, Ashish M Kamat, et al.
European Urology
|
September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Page
of 30